| Microbiome distinctions between the CRC carcinogenic pathways L DeDecker, B Coppedge, J Avelar-Barragan, W Karnes, K Whiteson Gut Microbes 13 (1), 1-12, 2021 | 46 | 2021 |
| Longitudinal analysis of the microbiome and metabolome in the 5xfAD mouse model of Alzheimer’s disease SJB Dunham, KA McNair, ED Adams, J Avelar-Barragan, S Forner, ... MBio 13 (6), e01794-22, 2022 | 18 | 2022 |
| Fecal microbial community composition in myeloproliferative neoplasm patients is associated with an inflammatory state A Oliver, K El Alaoui, C Haunschild, J Avelar-Barragan, LF Mendez Luque, ... Microbiology spectrum 10 (3), e00032-22, 2022 | 12 | 2022 |
| Distinct colon mucosa microbiomes associated with tubular adenomas and serrated polyps J Avelar-Barragan, L DeDecker, ZN Lu, B Coppedge, WE Karnes, ... npj Biofilms and Microbiomes 8 (1), 69, 2022 | 11 | 2022 |
| Characterizing the microbiome of patients with myeloproliferative neoplasms during a Mediterranean diet intervention J Avelar-Barragan, LF Mendez Luque, J Nguyen, H Nguyen, ... Mbio 14 (6), e02308-23, 2023 | 5 | 2023 |
| Low Volume Methodology for Nextera DNA Flex Library Prep Kit (96 Samples) E Adams, S Wandro, J Avelar-Barragan, A Oliver, K Whiteson | 4 | 2020 |
| The NUTRIENT trial (NUTRitional intervention among myEloproliferative Neoplasms): feasibility phase LFM Luque, J Avelar-Barragan, H Nguyen, J Nguyen, EM Soyfer, J Liu, ... medRxiv, 2023 | 3 | 2023 |
| Longitudinal analysis of the gut microbiome in the 5xfAD mouse model of Alzheimer’s disease SJB Dunham, KA McNair, ED Adams, J Avelar-Barragan, S Forner, ... bioRxiv, 2022.03. 02.482725, 2022 | 2 | 2022 |
| The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Results from a Randomized Phase I Pilot Study for Feasibility and Adherence LF Mendez Luque, J Avelar-Barragan, H Nguyen, J Nguyen, EM Soyfer, ... Cancer Research Communications 4 (3), 660-670, 2024 | 1 | 2024 |
| Mediterranean Diet intervention in patients with myeloproliferative neoplasm LF Mendez, J Li, J Avelar-Barragan, J Nguyen, H Nguyen, HE Kosiorek, ... Blood 140 (Supplement 1), 3972-3973, 2022 | 1 | 2022 |
| Fecal putative uropathogen abundance and antibiotic resistance gene carriage in women with refractory recurrent urinary tract infection treated with fecal microbiota … SES Jeney, J Avelar-Barragan, K Whiteson, J Chang, S Dutta, F Lane Urogynecology 28 (4), 213-219, 2022 | 1 | 2022 |
| Sex‐specific associations between AD genotype and the microbiome of human amyloid beta knock‐in (hAβ‐KI) mice SJB Dunham, J Avelar‐Barragan, JA Rothman, ED Adams, G Faraci, ... Alzheimer's & Dementia, 2024 | | 2024 |
| Specific gut microbial community is associated with specific cancer types: A strategy for cancer detection and prevention E Mittal, A Oliver, KE Alaoui, C Haunschild, J Avelar-Barragan, ... Cancer Research 83 (7_Supplement), 5908-5908, 2023 | | 2023 |
| Investigating the Interplay Between Diet, the Human Gut Microbiota, and Cancer J Avelar-Barragan University of California, Irvine, 2023 | | 2023 |
| Using gut microbiome analysis and machine learning approach for early cancer identification and treatments E Mittal, A Oliver, K El Alaoui, C Haunschild, J Avelar-Barragan, ... Journal of Biological Chemistry 299 (3), 103116, 2023 | | 2023 |
